Crowdonomics
Cizzle Bio, Inc.

Reg CF · Common Stock · Nov 2024

ClosedReached targetReg CFCommon Equity
via DealMaker · last checked Sep 25, 2026
Raised
$14.7K / $5M max
0% of ceiling
Investors
—
—
Post-money valuation
$70.5M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
FY2022
$0
−$440K
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$439,818
Taxes paid
$0
$0
Balance sheet
Cash
$0
$845,048
Accounts receivable
$0
$0
Total assets
$0
$845,048
Short-term debt
$0
$42,409
Long-term debt
$0
$1,228,500
Total liabilities
$0
$1,270,909
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Apr 17, 2025
    • Deadline Apr 20, 2025 → Apr 15, 2026

    “This material amendment is filed to, among other things, (i) extend the Offering deadline to April 15, 2026; (ii) reduce the Minimum Individual Purchase Amount; (iii) update the Perks; and (iv) provide 2024 audited financials for the Issuer and Co-Issuer.”

    Form C/A on EDGAR ↗
  2. Apr 17, 2025
    No change to filed terms

    “This non-material amendment is filed to (i) extend the Perks deadline to March 31, 2025; and (ii) update the Capitalization and Ownership, Financial Information and Previous Offerings sections.”

    Form C/A on EDGAR ↗
  3. Feb 3, 2025
    No change to filed terms

    “This non-material amendment is filed to (i) extend the Perks deadline to March 31, 2025; and (ii) update the Capitalization and Ownership, Financial Information and Previous Offerings sections.”

    Form C/A on EDGAR ↗
  4. Nov 4, 2024
    • Security Common Stock → Other: Class B Non-Voting Common Stock

    “This amendment is filed to correct a typographical error in the Deadline to reach the Target Offering Amount”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$70.5M
Post-money$70.5M
Price / share$0.38
Shares offered25,426

Offering details

Target$10,000
Max$5,000,000
Min investment—
OpenedNov 4, 2024
DeadlineApr 15, 2026
ClosedApr 15, 2026
Days active527

Links & provenance

Source: SEC EDGAR
0001062993-24-018218
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.